α2β1 Integrin Ligand Peptide interacts with the α2β1 integrin receptor on the cell membrane and mediates extracellular signals into cells. It is a potential antagonist of collagen receptors.
CAT No: R1760
CAS No:134580-64-6
Synonyms/Alias:H-Asp-Gly-Glu-Ala-OH;134580-64-6;DGEA;(4S)-4-[[2-[[(2S)-2-amino-3-carboxypropanoyl]amino]acetyl]amino]-5-[[(1S)-1-carboxyethyl]amino]-5-oxopentanoic acid;alpha2beta1 Integrin Ligand Peptide TFA;Asp-Gly-Glu-Ala;21 Integrin Ligand Peptide;SCHEMBL2789997;DTXSID90431344;a2b1Integrin Recognition Sequence;HY-P1868;DGEA, >=97% (TLC);MFCD00143573;alpha2beta1 Integrin Recognition Sequence;DA-59333;FI108428;CS-0097304;L-alpha-Aspartylglycyl-L-alpha-glutamyl-L-alanine;DGEA;21 Integrin Ligand Peptide;H-Asp-Gly-Glu-Ala-OH;(S)-4-(2-((S)-2-amino-3-carboxypropanamido)acetamido)-5-((S)-1-carboxyethylamino)-5-oxopentanoic acid;
1. Emu oil in combination with other active ingredients for treating skin imperfections
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.